2021 AM Posters-Kratom dependence, Can We Call It Use Disorder

Kratom dependence, Can We Call It Use Disorder - 1

Pdf Summary

This document discusses the case of a 30-year-old male who presented with kratom dependence, generalized anxiety disorder (GAD), and unspecified depression. Kratom is a naturally derived substance that is used to enhance mood and concentration and manage opioid withdrawal symptoms. It is derived from the leaves of a tree native to Southeast Asia. The active ingredients in kratom include 9-methoxy-corynantheidine and 7-hydroxymitragynine.<br /><br />The use of kratom has increased significantly in recent years, and it has been banned in several states and countries due to its stimulant and hallucinogenic properties. The pharmacology of kratom involves both stimulatory and sedative-narcotic effects, depending on the dosage. It is metabolized by the liver and can be detected through specific testing methods.<br /><br />Kratom withdrawal symptoms include nausea, sweating, muscle aches, fatigue, diarrhea, and mood disturbances. The management of kratom addiction involves supportive care, symptomatic management of withdrawal symptoms, and the use of opioid receptor agonists or partial agonists. There is a high risk of relapse, with a significant percentage of individuals relapsing within three months of treatment.<br /><br />The patient in this case is currently stable and sober from kratom with the help of buprenorphine-naloxone and duloxetine for anxiety disorder. The document also discusses the adverse effects and toxicity associated with kratom use, including seizures, psychosis, hallucinations, arrhythmias, and death.<br /><br />The patient's social history, employment, education, and legal history are also outlined in the document. Overall, there is a lack of guidelines for the long-term management of kratom addiction, and further research is needed to understand its effectiveness and potential risks.

Keywords

kratom dependence

generalized anxiety disorder

unspecified depression

mood enhancement

concentration enhancement

opioid withdrawal symptoms

kratom ban

stimulant properties

hallucinogenic properties

kratom pharmacology

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 307 East Providence, RI 02914 cmecpd@aaap.org	About Advocacy Membership Fellowship Education and Resources Training Events